Q-Pad Test System
Dec 2023
201d
Qurasense has submitted 1 FDA 510(k) premarket notifications since 2023, of which 1 received clearance as substantially equivalent to a predicate device.
The company's most frequent device categories include Assay, Glycosylated Hemoglobin . Use the specialty filter in the sidebar to narrow results.